Published on in Vol 6, No 10 (2022): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/34923, first published .
Mobile App to Enhance Patient Activation and Patient-Provider Communication in Major Depressive Disorder Management: Collaborative, Randomized Controlled Pilot Study

Mobile App to Enhance Patient Activation and Patient-Provider Communication in Major Depressive Disorder Management: Collaborative, Randomized Controlled Pilot Study

Mobile App to Enhance Patient Activation and Patient-Provider Communication in Major Depressive Disorder Management: Collaborative, Randomized Controlled Pilot Study

Maggie McCue   1 , RD, MS ;   Christopher Blair   1 , MS ;   Ben Fehnert   2, 3 , MA ;   James King   2, 3 , BSc ;   Francesca Cormack   2, 4 , PhD ;   Sara Sarkey   1 , PhD ;   Anna Eramo   5 , MD ;   Christopher Kabir   6 , MS ;   Rasha Khatib   6 , PhD ;   David Kemp   7 , MS, MD

1 Takeda Pharmaceuticals USA, Inc, Lexington, MA, United States

2 Cognition Kit, Cambridge, United Kingdom

3 Ctrl Group, London, United Kingdom

4 Cambridge Cognition, Cambridge, United Kingdom

5 Lundbeck LLC, Deerfield, IL, United States

6 Advocate Research Institute, Advocate Health Care, Downers Grove, IL, United States

7 Advocate Aurora Health, Downers Grove, IL, United States

Corresponding Author: